Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-16

Clinical Trial Update: Ustekinumab Plus UVB-311nm in Psoriasis [NA]

View source ↗

Summary

Clinical trial update noting completion of a study evaluating ustekinumab with UVB 311 nm phototherapy for psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Medical University of Graz | Conditions: Psoriasis | NA | Status: COMPLETED